Camptosar → Irinotecan

HRID 1614850

反応式

HRID 1614850 の反応式
[CH3:1][CH2:2][C:3]1[C:12]2[CH2:13][N:14]3[C:19](=[O:20])[C:18]4[CH2:21][O:22][C:23]([C@:25]([OH:28])([CH2:26][CH3:27])[C:17]=4[CH:16]=[C:15]3[C:11]=2[N:10]=[C:9]2[C:4]=1[CH:5]=[C:6]([O:29][C:30]([N:32]1[CH2:37][CH2:36][CH:35]([N:38]3[CH2:43][CH2:42][CH2:41][CH2:40][CH2:39]3)[CH2:34][CH2:33]1)=[O:31])[CH:7]=[CH:8]2)=[O:24].O.O.O.Cl.[Na].N[C@H](C(O)=O)CS(=O)(O)=O>CO>[CH3:1][CH2:2][C:3]1[C:12]2[CH2:13][N:14]3[C:19](=[O:20])[C:18]4[CH2:21][O:22][C:23]([C@:25]([OH:28])([CH2:26][CH3:27])[C:17]=4[CH:16]=[C:15]3[C:11]=2[N:10]=[C:9]2[C:4]=1[CH:5]=[C:6]([O:29][C:30]([N:32]1[CH2:33][CH2:34][CH:35]([N:38]3[CH2:43][CH2:42][CH2:41][CH2:40][CH2:39]3)[CH2:36][CH2:37]1)=[O:31])[CH:7]=[CH:8]2)=[O:24]

参加物

5

反応物 3

HCID 60837CamptosarHCID 72886L-Cysteic acidHCID 5360545Sodium

生成物 1

HCID 60838Irinotecan

試薬・触媒・溶媒 1

HCID 887Methanol溶媒

実験手順

Methanol stock-solutions of irinotecan hydrochloride trihydrate (100 ml, 1.15 mg/ml) and sodium salt of methyl ester of N-all-trans-retinoyl cysteic acid (27 ml, 15 mg/ml) were mixed in a 500 ml round-bottom flask and evaporated in vacuo. 100 ml of water was added to the residue obtained after evaporation and the mixture was stirred until it became clear and transparent (approx. 30 min). The concentration of irinotecan in the obtained solution was 1 mg/ml, corresponding to an irinotecan hydrochloride trihydrate concentration of 1.15 mg/ml. The obtained solution was filtered through 0.2 mm filter and freeze dried. The filtration did not result in reduction of irinotecan concentration.

後処理

  1. customevaporated in vacuo
  2. addition100 ml of water was added to the residue
  3. customobtained
  4. customafter evaporation
  5. customtransparent (approx. 30 min)
  6. filtrationThe obtained solution was filtered through 0.2 mm
  7. filtrationfilter
  8. customfreeze dried
  9. filtrationThe filtration

出典と根拠

ORDレコード
ord-170cc3a8259f48feaeec895636c2ce05
出典データセット
uspto-grants-2014_07
特許番号
US08765173B2

関連ノート

読み込み中…